CapsoVision vs Nano-X Imaging
CV and NNOX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CV and NNOX compare
Nano-X Imaging grew revenue faster over the last twelve months (15.4% versus 6.4% for CapsoVision).
CapsoVision keeps more of each dollar of sales as profit, with a net margin of −210% compared with −576% at Nano-X Imaging.
CapsoVision scores higher on the StockData Score (6 against 5 for Nano-X Imaging), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CV | NNOX |
|---|---|---|
| Size and price | ||
| Market cap | $302M | – |
| Share price | $6.03 | $0.322 |
| Change, 1 year | 8.8% | −89.4% |
| Change, 5 years | – | −98.3% |
| Beta (5Y) | −1.15 | 1.37 |
| Employees | 99 | 197 |
| StockData Score | ||
| Total score | 6 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 6 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 21.7× | – |
| P/B | 11.4× | – |
| FCF yield | −9.7% | – |
| Fair value | $1.25 | – |
| Margin of safety | −383% | – |
| Growth | ||
| Revenue growth (TTM) | 6.4% | 15.4% (better) |
| Profitability | ||
| Gross margin | 49.7% (better) | −98.2% |
| Operating margin | −212% (better) | −601% |
| Net margin | −210% (better) | −576% |
| FCF margin | −210% (better) | −346% |
| Return on equity | −125% | −63.6% (better) |
| Return on invested capital | −99.6% | −59.5% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.04 (better) |
| Current ratio | 5.07 (better) | 2.84 |
| Altman Z-score | 19.14 | – |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 10.2% | 13.9% |
| Held by insiders | 29.0% | 10.4% |
| Insider net buying, 12 months | $21.0M (better) | $190K |
| Short interest, % of float | 5.5% | 9.3% |
Go deeper
- CV stock overview
- CV income statement
- CV valuation and score
- NNOX stock overview
- NNOX income statement
- NNOX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.